Drug Delivery

Less than 1 min 06/05/21
Author name: John Ross

Patient Centric Drug Delivery

With patient experience driving a new wave of novel medicines, highly potent novel OSD drugs have gained popularity and show no signs of slowing down. In this article with Pharma Focus Asia, John Ross, President at Metrics Contract Services and Mayne Pharma US, explores the factors driving HPAPI manufacturing and the key components that are required to achieve successful and most importantly safe HPAPI operations. “Our characterization capabilities combined with key insight gained over many years of experience, ensure that the containment and handling practices of any HAPI project remain aligned.” Read the article on page 66 in Pharma Focus Asia’s ebook, Issue 41.


Related Content